8-chloro-1-methyl-6-phenyl-4H-s-triazolo<4,3-a><1,4>benzodiazepine-4-acetic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: 8-chloro-1-methyl-6-phenyl-4H-s-triazolo<4,3-a><1,4>benzodiazepine-4-acetic acid
• 英文别名: 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine-4-acetic acid；2-(8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)acetic acid
• 化学式: C₁₉H₁₅ClN₄O₂
• 分子量: 366.807
• InChiKey: QDKCFHXLUQBVRL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  80.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  阿普唑仑 在 sodium hydroxide 、 sodium hydride 作用下， 以 乙醇 为溶剂， 反应 37.33h， 生成 8-chloro-1-methyl-6-phenyl-4H-s-triazolo<4,3-a><1,4>benzodiazepine-4-acetic acid
  参考文献：
  名称：

  8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines with substituents at C-4

  摘要：

  A series of 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines with substituents at C-4 was prepared and evaluated for antianxiety potential. It was found that substitution at this position generally decreased the activity in this series.

  DOI：

  10.1021/jm00180a012

文献信息

• HESTER J. B. JR.; RUDZIK A. D.; VOIGTLANDER P. F. VON, J. MED. CHEM., 1980, 23, NO 6, 643-647
  作者：HESTER J. B. JR.、 RUDZIK A. D.、 VOIGTLANDER P. F. VON

  DOI：——

  日期：——
• MULTIVALENT AGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF THE GABA RECEPTORS
  申请人：Advanced Medicine, Inc.

  公开号：EP1085870A2

  公开（公告）日：2001-03-28
• [EN] MULTIVALENT AGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF THE GABA RECEPTORS<br/>[FR] AGONISTES POLYVALENTS, AGONISTES ET ANTAGONISTES PARTIELS DES RECEPTEURS DE GABA
  申请人：ADVANCED MEDICINE, INC.

  公开号：WO1999063933A2

  公开（公告）日：1999-12-16

  (EN) Disclosed are multibinding compounds which are agonists, partial agonists, inverse agonists, partial inverse agonist or antagonists of the GABA receptors, which are involved in neurological disorders. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is an agonist, partial agonist, inverse agonist, partial inverse agonist or antagonist of the GABA receptors. The multibinding compounds of this invention are useful in the treatment of neurological disorders such as anxiety, depression, sleep and seizure disorders, emesis and overdoses of benzodiazepine-type drugs, and producing sedation, hypnosis, retrograde amnesia, and enhancing alertness and the like.(FR) L'invention concerne des composés de liaison multiple, lesquels constituent des agonistes, des agonistes partiels, des agonistes inverses, des agonistes ou antagonistes partiels inverses des récepteurs de GABA (acide $g(g)-amino-butyrique) impliqués dans des troubles neurologiques. Les composés de liaison multiple de l'invention contiennent 2 à 10 ligands, liés de manière covalente à un ou plusieurs segments de liaison. Chaque ligand constitue un agoniste, un agoniste partiel, un agoniste inverse, un agoniste ou antagoniste partiel inverse des récepteurs de GABA. Les composés de liaison multiple de l'invention sont utiles dans le traitement de troubles neurologiques tels que l'anxiété, la dépression, les troubles du sommeil et les crises d'épilepsie, les vomissements et overdoses de médicaments du type benzodiazépines; ils sont également utiles pour produire la sédation et l'hypnose, l'amnésie rétrograde, et pour accroître la vigilance et analogue.
• 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines with substituents at C-4
  作者：Jackson B. Hester、Allan D. Rudzik、Philip F. VonVoigtlander

  DOI：10.1021/jm00180a012

  日期：1980.6

  A series of 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines with substituents at C-4 was prepared and evaluated for antianxiety potential. It was found that substitution at this position generally decreased the activity in this series.